Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
XOMA Royalty Corporation - Common Stock
(NQ:
XOMA
)
40.86
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 28, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
103
Open
40.86
Bid (Size)
40.75 (200)
Ask (Size)
43.89 (200)
Prev. Close
40.86
Today's Range
40.86 - 40.86
52wk Range
22.29 - 42.81
Shares Outstanding
11,782,723
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
XOMA Investors Have the Opportunity to Join Investigation of XOMA Royalty Corporation with the Schall Law Firm
April 28, 2026
From
Schall Law
Via
GlobeNewswire
XOMA Royalty Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of XOMA Royalty Corporation - XOMA
April 28, 2026
From
Kahn Swick & Foti, LLC
Via
Business Wire
Performance
YTD
+46.0%
+46.0%
1 Month
+35.1%
+35.1%
3 Month
+58.9%
+58.9%
6 Month
+17.4%
+17.4%
1 Year
+66.0%
+66.0%
More News
Read More
Halper Sadeh LLC is Investigating Whether OGN, XOMA, RMAX, SLNO are Obtaining Fair Deals for their Shareholders
April 27, 2026
From
Halper Sadeh LLC
Via
GlobeNewswire
XOMA Royalty Corporation (NASDAQ:XOMA) Passes Key Growth and Momentum Filters
↗
April 21, 2026
Via
Chartmill
XOMA Royalty Corporation (NASDAQ:XOMA) Passes Strict "Little Book" Growth Stock Screen
↗
March 31, 2026
Via
Chartmill
XOMA Royalty Corporation (NASDAQ:XOMA) Beats Q4 2025 Earnings Estimates, Stock Rises
↗
March 18, 2026
Via
Chartmill
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: XOMA Royalty Corporation (Nasdaq – XOMA), Organon & Co. (NYSE – OGN), RE/MAX Holdings, Inc. (NYSE – RMAX), Soleno Therapeutics, Inc. (Nasdaq – SLNO)
April 27, 2026
From
Brodsky & Smith LLC
Via
GlobeNewswire
XOMA Stock Alert: Halper Sadeh LLC is Investigating Whether XOMA Royalty Corporation is Obtaining a Fair Price for its Shareholders
April 27, 2026
From
Halper Sadeh LLC
Via
Business Wire
Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator
April 27, 2026
From
XOMA Royalty Corporation
Via
GlobeNewswire
XOMA Royalty Declares Quarterly Preferred Stock Dividends
March 18, 2026
From
XOMA Royalty Corporation
Via
GlobeNewswire
XOMA Royalty Jumps After Q4 Double Beat, Signals Pipeline Catalysts Ahead
↗
March 18, 2026
Via
Benzinga
XOMA Royalty Reports 2025 Financial Results and Highlights Recent Business Achievements
March 18, 2026
From
XOMA Royalty Corporation
Via
GlobeNewswire
Stock Market Today, March 16: CytomX Therapeutics Surges After Positive Phase 1 Colorectal Cancer Data
↗
March 16, 2026
Via
The Motley Fool
Topics
Stocks
XOMA Royalty to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026
March 12, 2026
From
XOMA Royalty Corporation
Via
GlobeNewswire
XOMA Royalty to Present at Investor Conferences in March
February 18, 2026
From
XOMA Royalty Corporation
Via
GlobeNewswire
XOMA Royalty Announces Closing of Tender Offer and Completed Acquisition of Generation Bio, Inc.
February 09, 2026
From
XOMA Royalty Corporation
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA
January 20, 2026
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA
January 13, 2026
From
Pomerantz LLP
Via
GlobeNewswire
XOMA Royalty Announces CFO Transition
January 12, 2026
From
XOMA Royalty Corporation
Via
GlobeNewswire
Unusual volume stocks in Wednesday's session
↗
January 07, 2026
Via
Chartmill
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA
January 06, 2026
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA
December 30, 2025
From
Pomerantz LLP
Via
GlobeNewswire
XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab
December 30, 2025
From
XOMA Royalty Corporation
Via
GlobeNewswire
XOMA Royalty Declares Quarterly Preferred Stock Dividends
December 22, 2025
From
XOMA Royalty Corporation
Via
GlobeNewswire
XOMA Royalty Enters into Agreement to Acquire Generation Bio
December 15, 2025
From
Generation Bio Co.; XOMA Royalty Corporation
Via
GlobeNewswire
Frequently Asked Questions
Is XOMA Royalty Corporation - Common Stock publicly traded?
Yes, XOMA Royalty Corporation - Common Stock is publicly traded.
What exchange does XOMA Royalty Corporation - Common Stock trade on?
XOMA Royalty Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for XOMA Royalty Corporation - Common Stock?
The ticker symbol for XOMA Royalty Corporation - Common Stock is XOMA on the Nasdaq Stock Market
What is the current price of XOMA Royalty Corporation - Common Stock?
The current price of XOMA Royalty Corporation - Common Stock is 40.86
When was XOMA Royalty Corporation - Common Stock last traded?
The last trade of XOMA Royalty Corporation - Common Stock was at 04/28/26 04:00 PM ET
What is the market capitalization of XOMA Royalty Corporation - Common Stock?
The market capitalization of XOMA Royalty Corporation - Common Stock is 481.44M
How many shares of XOMA Royalty Corporation - Common Stock are outstanding?
XOMA Royalty Corporation - Common Stock has 481M shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.